ABUS vs FAST
Arbutus Biopharma Corp (ABUS) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ABUS and FAST stock pages for the full models.
Not investment advice.